| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $89,494,837 ) (Continued on the next page) |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UM1TR005265 | Center for Clinical and Translational Science and Training | 002 | 2 | NIH | 9/3/2026 | $0 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | UM1TR005265 | Center for Clinical and Translational Science and Training | 001 | 2 | NIH | 7/1/2026 | $5,308,061 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K99HL181189 | Hematopoietic cells and chemokine regulation in abdominal aortic aneurysm associated thrombosis | 000 | 2 | NIH | 6/10/2026 | $156,276 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL163148 | Mitochondrial R-loop in sepsis-induced cardiomyopathy | 001 | 4 | NIH | 3/25/2026 | $13,745 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL163148 | Mitochondrial R-loop in sepsis-induced cardiomyopathy | 000 | 4 | NIH | 2/23/2026 | $435,256 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R03AG098738 | GLP-1 Agonists for Preventing Alzheimer's Disease in Mild Cognitive Impairment | 000 | 1 | NIH | 2/5/2026 | $324,000 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL187149 | CPNE5 in Cardiovascular Barrier Dysfunction and Septic Cardiomyopathy | 000 | 1 | NIH | 7/23/2026 | $753,539 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01ES037686 | Hepatotoxicity of Legacy and Replacement PFAS: Role of BRUCE-Mitochondrial Interactions | 000 | 1 | NIH | 6/11/2026 | $3,872,186 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01NS147345 | Proteomics and Cognitive Decline Following Intracerebral Hemorrhage | 000 | 1 | NIH | 3/5/2026 | $654,628 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R35GM158428 | Improving red blood cell storage for trauma resusciation | 000 | 2 | NIH | 8/19/2026 | $405,000 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01GM164373 | Mechanistic underpinnings of PRPS deficiency disorders | 000 | 1 | NIH | 7/30/2026 | $345,561 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01AT012909 | Immunological mechanisms underlying acupuncture analgesia in patients with sickle cell disease | 001 | 2 | NIH | 8/18/2026 | $643,433 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R34AA032824 | Developing and Evaluating a Firefighter Self-Administered Neurostimulation Intervention for Traumatic Stress to Reduce Alcohol Use | 000 | 1 | NIH | 5/1/2026 | $228,118 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01NS140155 | Metabolomics of ICH recovery (METABOL-ICH) | 000 | 2 | NIH | 5/11/2026 | $634,454 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01DA063296 | Single cell opioid (fentanyl) responses in the context of HIV | 001 | 2 | NIH | 3/20/2026 | $549,599 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01DK142998 | Feasibility, Acceptability, and Preliminary Phase II Efficacy Testing of a Community-Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding | 000 | 2 | NIH | 8/4/2026 | $322,917 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | DP1CA291173 | Effects of the oral environment on KSHV shedding in Ugandan adults living with HIV | 000 | 3 | NIH | 4/10/2026 | $567,000 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01AI172959 | Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir | 000 | 4 | NIH | 3/24/2026 | $540,176 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HD093694 | High-Intensity Interval Training to Recover Walking Post-Stroke: HIT-Stroke Trial 2 | 000 | 9 | NIH | 6/30/2026 | $678,686 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R37NS122141 | Neuromodulatory regulation of synaptic plasticity in spinal nociceptive circuits | 002 | 5 | NIH | 6/23/2026 | $601,309 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R03NS144870 | Role of NK cell subsets in an animal model of relapsing-remittingmultiple sclerosis | 000 | 2 | NIH | 8/7/2026 | $81,000 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K23HL164971 | Biomarker Discovery in Portopulmonary Hypertension | 000 | 4 | NIH | 3/7/2026 | $203,526 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL176858 | Elucidating the Sexual Cycle of HIV/AIDS-Related Pneumocystis Pneumonia | 001 | 2 | NIH | 7/23/2026 | $468,042 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K23DC022306 | Adapting ECHO for Autistic Children's Communication | 001 | 2 | NIH | 8/20/2026 | $191,268 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL176487 | Stress Regulated RNA Degradation in Cardiac Hypertrophy | 000 | 2 | NIH | 6/30/2026 | $634,383 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK106364 | On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia | 000 | 10 | NIH | 1/16/2026 | $605,994 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | F30HL172585 | Determining the regulatory role of microprotein ALN on SERCA2a and heart contractility | 002 | 2 | NIH | 5/15/2026 | $576 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | F30HL172585 | Determining the regulatory role of microprotein ALN on SERCA2a and heart contractility | 001 | 2 | NIH | 3/25/2026 | $54,538 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL168464 | A novel strategy for heart failure therapeutics | 001 | 3 | NIH | 3/30/2026 | $16,615 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R37CA272854 | Investigating the molecular mechanisms of growth in GNAS mutant pancreatic cancer. | 000 | 5 | NIH | 7/28/2026 | $370,575 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL168464 | A novel strategy for heart failure therapeutics | 000 | 3 | NIH | 2/12/2026 | $526,150 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01AG084834 | Optimizing CNS DHA delivery in elderly adults at risk for dementia | 000 | 3 | NIH | 9/14/2026 | $735,554 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K01DA054339 | Circuit-Selective Astroglial Plasticity During Opioid Relapse | 000 | 5 | NIH | 7/24/2026 | $183,546 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01EB035594 | Designing a deployable and adaptable plasmonic sensing platform for infectious disease surveillance | 000 | 3 | NIH | 4/21/2026 | $333,248 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | T35DK060444 | Short-Term Institutional Research Training Grant | 000 | 23 | NIH | 6/30/2026 | $75,578 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U01CA267985 | Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy | 002 | 5 | NIH | 8/18/2026 | $0 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U01CA267985 | Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy | 001 | 5 | NIH | 4/16/2026 | $36,954 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01CA267985 | Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy | 000 | 5 | NIH | 1/29/2026 | $332,557 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R00ES036311 | Identifying critical mediators of ovarian and cardiovascular health | 000 | 3 | NIH | 12/24/2025 | $248,999 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01HL183489 | Targeted rewiring of a fibrosis driver to enhance cardiac reprogramming | 000 | 1 | NIH | 7/7/2026 | $1,570,460 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R21DC023496 | Characterizing late talking in prematurity using neuroimaging and language sample analysis | 000 | 1 | NIH | 7/6/2026 | $458,331 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01ES037647 | Impact of Micro- and Nanoplastics on Heart Health and Disease | 000 | 1 | NIH | 3/31/2026 | $698,212 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01GM156796 | Fundamental properties of circadian rhythms | 000 | 2 | NIH | 7/24/2026 | $380,089 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U54HL188781 | Clinical Trial Readiness for Rare Lung Diseases | 000 | 1 | NIH | 9/4/2026 | $1,757,693 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R50CA305011 | NCI-Sponsored Leadership Focused on Clinical Trial Enrollment | 000 | 1 | NIH | 9/7/2026 | $240,272 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U54HL188781 | Clinical Trial Readiness for Rare Lung Diseases | 000 | 1 | NIH | 9/4/2026 | $1 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | U54HL188781 | Clinical Trial Readiness for Rare Lung Diseases | 000 | 1 | NIH | 9/4/2026 | $1 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | R01EB038223 | Advancing Chemically-Modified Aptamers for Ultra-Sensitive Biomonitoring at the Picomolar-to-Nanomolar Scale | 000 | 1 | NIH | 9/1/2026 | $398,400 |
| | 2026 | 2026 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220 | HAMILTON | USA | K23HL183818 | Mapping Activated Microglia and Their Effect on Cognitive Deficits in Adults with Sickle Cell Disease | 000 | 1 | NIH | 4/8/2026 | $186,613 |
|
